FDA approves reduced dosing of Orfadin for HT-1 sufferers
Orfadin, a drug used to treat a condition causing kidney and liver damage, has now received the FDA’s go-ahead for once-a-day use, cutting its dosing frequency in half. Read More »
Endo ships generic Sabril following FDA approval
Endo International plc of Dublin, Ireland recently launched shipping operations for its generic Sabril (vigabatrin for oral solution USP, 500 mg) product via Par Pharmaceutical, following final approval of its Abbreviated New Drug Application (ANDA). Read More »
Coherus BioSciences reveals positive outcome for biosimilar PK/BE study
Coherus BioSciences Inc. of Redwood City, California recently announced initial results from several current clinical pharmacokinetic bioequivalence (PK/BE) studies comparing two products, both developed for the purpose of addressing certain chronic arthritic and skin conditions. Read More »
Merck and University of Oxford release positive results from REVEAL study of anacetrapib
Merck and researchers from the Clinical Trial Service Unit at the University of Oxford recently announced positive results for the REVEAL Study. Read More »
Novartis's Kymriah approved by FDA to treat acute lymphoblastic leukemia
Novartis recently announced that the U.S. Food and Drug Administration (FDA) approved Kymriah suspension for intravenous infusion for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse. Read More »
Ascend Therapeutics, Egalet Corp. offer new opioid-free painkiller delivered via nasal spray
The makers of a new, opioid-free inhalable pain reliever have launched a campaign to market the drug to more than 9,000 women’s healthcare providers across the U.S. this fall. Read More »
Rite Aid rolls out KidCents Safe Medication Disposal Program
The Rite Aid Foundation recently announced the rollout of its KidCents Safe Medication Disposal Program, which will focus on reducing drug accessibility, medication misuse and accidental poisoning of children and adolescents. Read More »
OPINION: Next Step in Dismantling Obamacare: IPAB
Taxes are lower, ISIS is on the run, and the regulatory agencies are in a ceasefire with the US economy. Read More »
Lannett gains approval for generic Nexium in time-released capsules
A generic formulation of AstraZeneca’s Nexium medication that delivers time-released doses of the drug to aid acid-reflux sufferers has received FDA approval and should soon be available for purchase. Read More »
ScriptSave WellRx wins conference product class award
ScriptSave WellRx earned honors at the National Association of Chain Drug Stores (NACDS) Total Store Expo (TSE) this year in San Diego, California, for its Personalized Wellness, designated the front end services product showcase winner. Read More »
Pfizer’s FDA-approved Besponsa leukemia drug finds new distributor
Officially approved for leukemia treatment by the FDA just one month ago, Pfizer Inc.’s BESPONSA has gained a primary distributor to provide the drug to pharmacies across the U.S. Read More »
NATIONAL INSTITUTES OF HEALTH: NIH launches partnership to improve success of clinical trials for patients with Parkinson’s disease
The National Institutes of Health is teaming with government, biopharmaceutical, life science and non-profit organizations to overcome obstacles and increase success for advancing promising treatments for Parkinson’s disease (PD). Read More »
AMGEN INC.: Amgen Receives CHMP Positive Opinion To Add Updated Overall Survival Data To KYPROLIS® (carfilzomib) Label
Label Variation to Include Overall Survival Data From Phase 3 ENDEAVOR Trial Read More »
MALLINCKRODT PHARMACEUTICALS: First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Pulmonary Sarcoidosis
Mallinckrodt plc confirmed enrollment of the first patient in the company's Phase 4, multi-center, randomized, double-blind, placebo-controlled pilot study to further assess the efficacy of H.P. Read More »
UPPER-SMITH LABORATORIES, INC: Upsher-Smith Receives FDA Approval for Bumetanide Tablets, USP
Upsher-Smith Laboratories, LLC (Upsher-Smith) announced that it has received U.S. Food and Drug Administration (FDA) approval of its abbreviated new drug application (ANDA) for Bumetanide Tablets, USP, 0.5 mg, 1 mg, and 2 mg. Read More »
WALGREENS: Walgreens Awarded U.S. Patent for its Connected Care® Oncology Program
Proprietary technology enables and helps guide specialty pharmacist interactions with patients prescribed oral oncology medications Read More »
MCKESSON, INC.: McKesson Medical-Surgical to Offer New Sysmex Device That Provides Blood Test Results at Point of Care in Minutes
McKesson Medical-Surgical and Sysmex America today announced plans for McKesson to be the exclusive distribution partner for Sysmex's new XW-100 automated hematology analyzer, the first Clinical Laboratory Improvement Amendments (CLIA)-waived, complete blood count (CBC) diagnostic instrument. Read More »
CVS HEALTH: CVS Health Offering No Cost "Know Your Numbers" Heart Health Screenings As Part of Its National Support of American Heart Association's Go Red For Women® Movement
As part of its continued support of the American Heart Association's Go Red For Women movement, CVS Health extended its commitment to women's health by offering no cost Read More »
SOMALOGIC: SomaLogic Teams with Leeds Centre for Personalised Medicine and Health to Deliver SOMAscan® Platform in Clinical Healthcare
SomaLogic announced today the establishment of a framework "Partnership for Personalized Health" with the Leeds Centre for Personalised Medicine and Health (CPMH) Read More »
LABCYTE: Labcyte Introduces New Acoustic Sample Management Solution
Labcyte issued the following announcement on Feb. 5.Labcyte Inc. today launched the Access™ Dual-Robot System (DRS) and the Echo® 655T Liquid Handler Read More »
Alerts Sign-up